These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 59388)

  • 21. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
    Cooper EH; Bauer HW; Dati F
    Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.
    Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW
    Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial comment.
    Carter HB
    Urology; 2009 Jul; 74(1):183; aurhor reply 183-4. PubMed ID: 19567300
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical morphological studies of prostate carcinoma. The potentials of aspiration biopsy in diagnosing prostate diseases in 180 cases].
    Atanasov N; Kumanov Kh; Vulkov I; Tsvetkov M; Topov Iu
    Khirurgiia (Sofiia); 1979; 32(1):48-52. PubMed ID: 88542
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigen. N. E. Stavropoulos et al. Br. J. Urol., 71, 309-312, 1993.
    Zarifis I; Zorzos I; Doumas K; Likourinas M
    Br J Urol; 1993 Nov; 72(5 Pt 1):673. PubMed ID: 10071575
    [No Abstract]   [Full Text] [Related]  

  • 26. Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
    Ammar H; Malani AK; Gupta C
    BMJ; 2006 Sep; 333(7569):654; author reply 654. PubMed ID: 16990336
    [No Abstract]   [Full Text] [Related]  

  • 27. [Electron-microscopic studies of the normal prostate, prostatic hypertrophy and prostatic carcinoma].
    Kirchheim D; Bacon RL
    Urologe; 1968; 7(5):292-305. PubMed ID: 4178530
    [No Abstract]   [Full Text] [Related]  

  • 28. Spectrum of histological lesions in 185 consecutive prostatic specimens.
    Mittal BV; Amin MB; Kinare SG
    J Postgrad Med; 1989 Jul; 35(3):157-61. PubMed ID: 2483935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphogenesis of prostatic carcinoma.
    McNeal JE
    Cancer; 1965 Dec; 18(12):1659-66. PubMed ID: 4158629
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.
    Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL
    Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine disturbances in men with benign hyperplasia and carcinoma of the prostate. A morphological study in an autopsy series.
    Harbitz TB; Haugen OA
    Acta Pathol Microbiol Scand A; 1974; ():Suppl244:1-13. PubMed ID: 4131409
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atypical hyperplasia of the prostate: coincidence with invasive carcinoma. A study of 69 prostatectomy preparations].
    Garske U; Bittinger A; Weingärtner K; Neumann K
    Verh Dtsch Ges Pathol; 1993; 77():78-81. PubMed ID: 7511307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial comment to When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy?
    Montironi R; Cheng L; Lopez-Beltran A; Mazzucchelli R; Scarpelli M
    Int J Urol; 2011 Feb; 18(2):153-4. PubMed ID: 21272085
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostatic carcinoma.
    Klein LA
    N Engl J Med; 1979 Apr; 300(15):824-33. PubMed ID: 106277
    [No Abstract]   [Full Text] [Related]  

  • 35. [Occult cancer in patients with symptomatic benign prostatic hyperplasia].
    Rodríguez Duarte C; Aguillón J; Rodríguez H
    Arch Esp Urol; 1991 May; 44(4):411-4. PubMed ID: 1712190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Magnetic resonance tomography in prostatic carcinoma and benign prostatic diseases with an endorectal and a new combined endorectal body phased-array coil].
    Engelhard K; Hollenbach HP; Ott G; Hausmann J; Risse W; Riedl C
    Rontgenpraxis; 1999; 52(7):214-23. PubMed ID: 10605323
    [No Abstract]   [Full Text] [Related]  

  • 37. A unifying hypothesis that links benign prostatic hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Invited comments.
    Harvey H
    Pathol Res Pract; 1995 Sep; 191(9):924-34. PubMed ID: 8606875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathomorphologic and pathogenetic study on 281 cases of prostatic hyperplasia].
    Luo AT
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):101-3. PubMed ID: 6190540
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostate cancer. Epidemiology.
    Alderson MR
    Recent Results Cancer Res; 1981; 78():1-19. PubMed ID: 6168010
    [No Abstract]   [Full Text] [Related]  

  • 40. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.